Literature DB >> 18373699

Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

A Komatsuda1, H Wakui, K Iwamoto, M Ozawa, M Togashi, R Masai, N Maki, T Hatakeyama, K Sawada.   

Abstract

Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373699      PMCID: PMC2453201          DOI: 10.1111/j.1365-2249.2008.03646.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Induction of clinical autoimmune disease by therapeutic interferon-alpha.

Authors:  Carmen Gota; Leonard Calabrese
Journal:  Autoimmunity       Date:  2003-12       Impact factor: 2.815

2.  Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.

Authors:  Robert Berland; Luis Fernandez; Elina Kari; Jin-Hwan Han; Ina Lomakin; Shizuo Akira; Henry H Wortis; John F Kearney; Angelo A Ucci; Thereza Imanishi-Kari
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  Systemic lupus erythematosus.

Authors:  David P D'Cruz; Munther A Khamashta; Graham R V Hughes
Journal:  Lancet       Date:  2007-02-17       Impact factor: 79.321

Review 4.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

5.  Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Authors:  R J Cook; D D Gladman; D Pericak; M B Urowitz
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

6.  Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.

Authors:  Eva D Papadimitraki; Christianna Choulaki; Eleni Koutala; George Bertsias; Christos Tsatsanis; Irini Gergianaki; Amalia Raptopoulou; Heraklis D Kritikos; Clio Mamalaki; Prodromos Sidiropoulos; Dimitrios T Boumpas
Journal:  Arthritis Rheum       Date:  2006-11

Review 7.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 9.  A protective role for innate immunity in systemic lupus erythematosus.

Authors:  Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

10.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  70 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 3.  Pattern recognition receptors in immune disorders affecting the skin.

Authors:  Heleen D de Koning; Anna Simon; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Innate Immun       Date:  2012-03-06       Impact factor: 7.349

Review 4.  Toll-like receptors and lupus nephritis.

Authors:  Fabrizio Conti; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

5.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 6.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

Review 7.  Immune sensing of nucleic acids in inflammatory skin diseases.

Authors:  Olivier Demaria; Jeremy Di Domizio; Michel Gilliet
Journal:  Semin Immunopathol       Date:  2014-09-16       Impact factor: 9.623

8.  Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.

Authors:  Nicholas A Young; Lai-Chu Wu; Craig J Burd; Alexandra K Friedman; Benjamin H Kaffenberger; Murugesan V S Rajaram; Larry S Schlesinger; Hayley James; Margaret A Shupnik; Wael N Jarjour
Journal:  Clin Immunol       Date:  2014-01-24       Impact factor: 3.969

Review 9.  Targeting Toll-like receptors for treatment of SLE.

Authors:  Christopher G Horton; Zi-jian Pan; A Darise Farris
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

10.  B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice.

Authors:  Sun-Hee Hwang; Huiyin Lee; Miwako Yamamoto; Leigh A Jones; Jivanaah Dayalan; Richard Hopkins; Xin J Zhou; Felix Yarovinsky; John E Connolly; Maria A Curotto de Lafaille; Edward K Wakeland; Anna-Marie Fairhurst
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.